Matteo Cassandri

11PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyElectrochemical energy storage and conversionMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 14, 2025
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes.

Silvia Pomella, Lucrezia D'Archivio, Matteo Cassandri

|Aug 06, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.

Matteo Cassandri, Antonella Porrazzo, Silvia Pomella

|Mar 13, 2024
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma.

Silvia Codenotti, Leonardo Sandrini, Delia Mandracchia

|Apr 28, 2023
ZFP750 affects the cutaneous barrier through regulating lipid metabolism.

Alessio Butera, Massimiliano Agostini, Matteo Cassandri

|Feb 11, 2023
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma.

Silvia Pomella, Matteo Cassandri, Ombretta Melaiu

|Nov 11, 2022
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma.

Silvia Pomella, Antonella Porrazzo, Matteo Cassandri

Pageof 2

Frequent Collaborators

8 joint publications

Rossella Rota

6 joint publications

Silvia Pomella

4 joint publications

Simona Camero

3 joint publications

Cinzia Marchese